Search Results

There are 2978 results for: content related to: Reply

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Discovery and Development of Entecavir

    Antiviral Drugs: From Basic Discovery through Clinical Trials

    Richard Wilber, Bruce Kreter, Marc Bifano, Stephanie Danetz, Lois Lehman-McKeeman, Daniel J. Tenney, Nicholas Meanwell, Robert Zahler, Helena Brett-Smith, Pages: 401–416, 2011

    Published Online : 20 JUN 2011, DOI: 10.1002/9780470929353.ch28

  3. Entecavir: A New Nucleoside Analog for the Treatment of Chronic Hepatitis B Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 12, December 2006, Pages: 1745–1757, Keri A. Sims and Abigail M. Woodland

    Version of Record online : 11 JAN 2012, DOI: 10.1592/phco.26.12.1745

  4. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  5. You have free access to this content
    Does long-term entecavir treatment really reduce hepatocellular carcinoma incidence in patients with hepatitis B virus infection?

    Hepatology

    Volume 59, Issue 5, May 2014, Page: 2053, Gin-Ho Lo

    Version of Record online : 24 MAR 2014, DOI: 10.1002/hep.26773

  6. Entecavir Pharmacokinetics, Safety, and Tolerability After Multiple Ascending Doses in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 11, November 2006, Pages: 1250–1258, Dr Jing-He Yan, Mr Marc Bifano, Mr Steven Olsen, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006293304

  7. You have free access to this content
    Entecavir treatment for up to 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 422–430, Ting-Tsung Chang, Ching-Lung Lai, Seung Kew Yoon, Samuel S. Lee, Henrique Sergio M. Coelho, Flair Jose Carrilho, Fred Poordad, Waldemar Halota, Yves Horsmans, Naoky Tsai, Hui Zhang, Daniel J. Tenney, Ricardo Tamez and Uchenna Iloeje

    Version of Record online : 4 JAN 2010, DOI: 10.1002/hep.23327

  8. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 892–898, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 30 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06161.x

  9. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma

    Liver Transplantation

    Volume 22, Issue 5, May 2016, Pages: 627–634, Elizabeth L. Yanik, Srinath Chinnakotla, Sally K. Gustafson, Jon J. Snyder, Ajay K. Israni, Dorry L. Segev and Eric A. Engels

    Version of Record online : 26 APR 2016, DOI: 10.1002/lt.24395

  10. You have free access to this content
    03. Endoscopy-128

    Journal of Gastroenterology and Hepatology

    Volume 24, Issue s1, October 2009, Pages: A78–A122,

    Version of Record online : 21 SEP 2009, DOI: 10.1111/j.1440-1746.2009.06083_3.x

  11. Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 5, May 2014, Pages: 1028–1034, Wai-Kay Seto, Yuk-Fai Lam, James Fung, Danny Ka-Ho Wong, Fung-Yu Huang, Ivan Fan-Ngai Hung, Ching-Lung Lai and Man-Fung Yuen

    Version of Record online : 21 APR 2014, DOI: 10.1111/jgh.12476

  12. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 120–127, G. V. Papatheodoridis, S. Manolakopoulos, G. Touloumi, G. Nikolopoulou, M. Raptopoulou-Gigi, C. Gogos, I. Vafiadis-Zouboulis, D. Karamanolis, A. Chouta, A. Ilias, C. Drakoulis, K. Mimidis, I. Ketikoglou, E. Manesis, M. Mela, G. Hatzis, G. N. Dalekos and for the HepNet.Greece Study Group

    Version of Record online : 15 JUL 2014, DOI: 10.1111/jvh.12283

  13. A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection

    The Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2015, Pages: 288–297, Shan-Ru Zuo, Xiao-Cong Zuo, Chun-Jiang Wang, Yu-Tao Ma, Hao-Ye Zhang, Zuo-Jun Li, Li-Ying Song, Zhen-Zhen Deng and Shi-Kun Liu

    Version of Record online : 20 NOV 2014, DOI: 10.1002/jcph.409

  14. Successful hepatocellular carcinoma downstaging with transarterial chemoembolization followed by stereotactic radiotherapy

    Liver Transplantation

    Volume 22, Issue 4, April 2016, Pages: 547–551, Rojymon Jacob, Souheil Saddekni, Laura Dover and Derek A. DuBay

    Version of Record online : 28 MAR 2016, DOI: 10.1002/lt.24398

  15. You have free access to this content
    Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing

    Clinical Microbiology and Infection

    Volume 18, Issue 10, October 2012, Pages: E404–E411, S.-Y. Ko, H.-B. Oh, C.-W. Park, H. C. Lee and J.-E. Lee

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1469-0691.2012.03951.x

  16. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  17. Absence of a Pharmacokinetic Interaction Between Entecavir and Adefovir

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1327–1334, Mr Marc Bifano, Dr Jing-He Yan, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007304780

  18. You have free access to this content
    06. Hepatoma-33

    Journal of Gastroenterology and Hepatology

    Volume 24, Issue s1, October 2009, Pages: A155–A167,

    Version of Record online : 21 SEP 2009, DOI: 10.1111/j.1440-1746.2009.06083_6.x

  19. Chronic Hepatitis B Viral Infection

    Textbook of Gastroenterology

    Robert G. Gish, Stephen Locarnini, Pages: 2112–2138, 2009

    Published Online : 17 FEB 2009, DOI: 10.1002/9781444303254.ch81

  20. Week 4 viral load predicts long-term suppression of HBV DNA during antiviral therapy: improving hepatitis B treatment in the real world

    Internal Medicine Journal

    Accepted manuscript online: 30 AUG 2016, Jennifer Truong, Bruce Shadbolt, Marie Ooi, Shivakumar Chitturi, Graham Kaye, Geoffrey C. Farrell and Narci C. Teoh

    DOI: 10.1111/imj.13244